| Carbobenzoxyproline |
Acalabrutinib |
1148-11-4 |
R&D |
|
No COA |
|
| Sr No |
Weight |
Price |
Availability |
Quote |
| No pricing available. |
|
| (4-(Pyridin-2-ylcarbamoyl)phenyl)boronic acid |
Acalabrutinib |
850568-25-1 |
R&D |
|
No COA |
|
| Sr No |
Weight |
Price |
Availability |
Quote |
| No pricing available. |
|
| (S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate |
Acalabrutinib |
1420478-88-1 |
R&D |
|
No COA |
|
| Sr No |
Weight |
Price |
Availability |
Quote |
| No pricing available. |
|
| (3-Chloropyrazin-2-yl)methanamine hydrochloride |
Acalabrutinib |
939412-86-9 |
R&D |
|
No COA |
|
| Sr No |
Weight |
Price |
Availability |
Quote |
| No pricing available. |
|
| rel-(1R,3r,5S)-3-Hydroxyspiro[bicyclo[3.2.1]octane-8,1'-pyrrolidin]-8-ium chloride |
Trospium chloride |
3464-71-9 |
R&D |
|
No COA |
|
| Sr No |
Weight |
Price |
Availability |
Quote |
| No pricing available. |
|
| (3-endo)-8-Azabicyclo[3.2.1]octan-3-ol |
Trospium chloride |
538-09-0 |
R&D |
|
No COA |
|
| Sr No |
Weight |
Price |
Availability |
Quote |
| No pricing available. |
|
| endo-8-Methyl-8-azabicyclo[3.2.1]octan-3-ol |
Trospium chloride |
120-29-6 |
R&D |
.png)
|
No COA |
|
| Sr No |
Weight |
Price |
Availability |
Quote |
| No pricing available. |
|
| (R)-(3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate |
Linezolid |
174649-09-3 |
R&D |
|
No COA |
|
| Sr No |
Weight |
Price |
Availability |
Quote |
| No pricing available. |
|
| 3-fluoro-4-morpholinylaniline |
Linezolid |
93246-53-8 |
R&D |
|
No COA |
|
| Sr No |
Weight |
Price |
Availability |
Quote |
| No pricing available. |
|
| tert-Butyl 4-(6-((7-cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
Ribociclib |
�1374639-78-7 |
R&D |
|
No COA |
|
| Sr No |
Weight |
Price |
Availability |
Quote |
| No pricing available. |
|
|
Disclaimer: Products protected by valid patents are not offered where sale constitutes infringement.
|
